Today’s WALL STREET JOURNAL (1/6/11) features USF School of Business and Professional Studies and an interview with Dean Mike Duffy. The school is recognized as a leader in the practice of incorporating real-world corporate feedback into our curriculum.
WSJ brings special attention to our recently developed four-course biotech sequence on developing, financing, and marketing new drugs — an area most MBA curricula fail to address. Paul Hastings, President and CEO of OncoMed of Redwood City, is quoted praising how the school approached him for consultation in making our MBA students more valuable to the biotech industry, which is burgeoning in the Bay Area.
The article also mentions that a group of our graduate students (both MBA and MSIS, ie: Information Systems) are currently participating in our Academic Global Immersion program, meeting with biotech executives and leaders in business, government and the media in London, Oxford, and Cambridge England. Director of the AGI trip is faculty member Dr. Moira Gunn who is also host of the national PBS programs TECH NATION and BIOTECH NATION.
Click here to read about USF in WSJ.
